MetLife Investment Management LLC Has $142.02 Million Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

MetLife Investment Management LLC reduced its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 2.2% in the 3rd quarter, Holdings Channel reports. The institutional investor owned 242,904 shares of the healthcare conglomerate’s stock after selling 5,487 shares during the quarter. UnitedHealth Group accounts for about 0.8% of MetLife Investment Management LLC’s investment portfolio, making the stock its 14th biggest holding. MetLife Investment Management LLC’s holdings in UnitedHealth Group were worth $142,021,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also recently bought and sold shares of UNH. China Universal Asset Management Co. Ltd. raised its holdings in UnitedHealth Group by 20.6% during the first quarter. China Universal Asset Management Co. Ltd. now owns 10,867 shares of the healthcare conglomerate’s stock worth $5,376,000 after acquiring an additional 1,857 shares in the last quarter. Quent Capital LLC increased its holdings in UnitedHealth Group by 5.5% during the first quarter. Quent Capital LLC now owns 4,196 shares of the healthcare conglomerate’s stock worth $2,076,000 after buying an additional 217 shares during the last quarter. Coppell Advisory Solutions Corp. acquired a new stake in UnitedHealth Group in the 1st quarter valued at about $752,000. Advisory Resource Group acquired a new position in UnitedHealth Group in the 1st quarter valued at about $209,000. Finally, Vima LLC increased its stake in shares of UnitedHealth Group by 40.3% during the first quarter. Vima LLC now owns 411 shares of the healthcare conglomerate’s stock worth $194,000 after purchasing an additional 118 shares during the period. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Up 0.3 %

NYSE UNH opened at $608.54 on Wednesday. The business’s fifty day simple moving average is $583.53 and its 200-day simple moving average is $554.65. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm has a market cap of $560.03 billion, a PE ratio of 39.64, a P/E/G ratio of 1.78 and a beta of 0.58. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The business had revenue of $100.82 billion during the quarter, compared to the consensus estimate of $99.14 billion. During the same quarter in the previous year, the firm posted $6.56 earnings per share. The company’s quarterly revenue was up 9.2% compared to the same quarter last year. As a group, equities analysts anticipate that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be issued a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.38%. The ex-dividend date is Monday, December 9th. UnitedHealth Group’s dividend payout ratio is presently 54.72%.

Analysts Set New Price Targets

Several research firms have recently issued reports on UNH. Royal Bank of Canada reduced their target price on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a report on Wednesday, October 16th. Stephens decreased their target price on UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating on the stock in a research report on Wednesday, October 16th. Truist Financial reiterated a “buy” rating and issued a $625.00 target price (down from $640.00) on shares of UnitedHealth Group in a report on Wednesday, October 16th. TD Cowen upped their price objective on shares of UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a research note on Friday, October 18th. Finally, UBS Group dropped their target price on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a research report on Wednesday, October 16th. Four equities research analysts have rated the stock with a hold rating, seventeen have given a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $618.26.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.